Predictmedix strikes partnership to distribute its Safe Entry Stations

Predictmedix strikes partnership to distribute its Safe Entry Stations

Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) has announced the expansion of its Safe Entry program with SBL Testing Technologies Inc (SBL) in partnership with Juiceworks Exhibits (JUICEWORKS).  Veterans in risk mitigation, Predictmedix said SBL has a long-standing reputation for being at the forefront of innovation in workplace safety, particularly for industrial clients in the energy and resource sectors.  With a strong presence in Canada and the US, established multinational clientele, and key partnerships with companies such as Sparta Group, the company noted that SBL is also aggressively positioned to permeate the industrial vertical with this new offering. Its territory will include North America and the Caribbean.  READ: Predictmedix set to deploy its Safe Entry Stations at the Italian Contemporary Film Festival Safe Entry Stations are powered by a proprietary artificial intelligence (AI) algorithm developed by Predictmedix. The clinically-based AI was designed by data scientists and clinicians to identify multiple symptoms of infectious disease, displaying the result in the form of a red or green light. The technology can also be configured to screen for impairment by THC and alcohol. All screening is entirely autonomous and designed to protect the privacy of the end-user. Completely unique to other solutions on the market, the AI is currently patent pending in North America. “SBL is an ideal partner to bring this technology to market. They have a unique perspective on the space, having been immersed in it for many years, and appreciate the value of the solution as a long-term risk mitigation tool,” said Jonathan Auger, president and founder of JUICEWORKS, in a statement. Rich Robillard, managing director of SBL, said Safe Entry is a critical risk mitigation tool for today’s workplace, given the current COVID-19 pandemic and further waves or variants, among other disease threats. “The ability to objectively screen for infectious disease symptoms non-invasively and in seconds presents an entirely new first layer of risk mitigation,” he said. Dr Rahul Kushwah, COO of Predictmedix, added: “The market positioning of SBL in workplace health safety and testing technologies provides us with an ideal partner to scale SAFE ENTRY both for infectious disease screening along with impairment screening all over North America and the Caribbean. Furthermore, the executive team at SBL has a clear vision and action plan for SAFE ENTRY which aligns with the long-term vision of Predictmedix.” Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham

Post a Comment